A Phase 2b Randomized Study to Assess the Efficacy and Safety of Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin's Lymphoma
Disease Types
Lymphoma
Available at
Bethesda, Columbia, Rockville, Silver Spring, Wheaton
Contact
Linda Iovanni
MOHRSCH@usoncology.com